Take home message
Splenda is the most popular artificial sweetener. It is heat stable and can be used in baking.
The FDA reviewed more than 110 studies before, in 1998, approving it as an artificial sweetener.
The results of the studies showed no evidence that it can cause cancer or pose a threat to human health.
Per FDA, the amount that a normal person can consume the equivalent of 23 Splenda packets every day for an entire lifetime, without an adverse health effect.
Thank you for reading Food4Thought.Today.
If you enjoyed it, please share it with your friends by email. If you are viewing this on a mobile device, click on "view the web version" to access the "follow by email" options.
American Heart Association's statement regarding artificial sweeteners
NIH: Cancer Research Institute's statement regarding artificial sweeteners
Bradstock, MK and others. Evaluation of reactions to food additives: the aspartame experience. Journal of Clinical Nutrition, March 1986.
Carlson, HE and JH Shah. Aspartame and its constituent amino acids: effects on prolactin, cortisol, growth hormone, insulin, and glucose in normal humans. Journal of Clinical Nutrition, March 1989.
Dagfinn, Arne. Soft drinks, aspartame, and the risk of cancer and cardiovascular disease. Journal of Clinical Nutrition, December 2012.
Drewnowski, A and others. Comparing the effects of aspartame and sucrose on motivational ratings, taste preferences, and energy intakes in humans. Journal of Clinical Nutrition, February 1994.
Nutrition 101: Replacing Sugar by Nonnutritive Sweeteners, Nutrition 101 Macronutrients Lesson 3.3, Dr Sander Kirstein,
Rodin, J Comparative effects of fructose, aspartame, glucose, and water preloads on calorie and macronutrient intake, Journal of Clinical Nutrition, March 1990.
Schernhammer, Eva S. and others. Consumption of artificial sweetener– and sugar-containing soda and risk of lymphoma and leukemia in men and women. Journal of Clinical Nutrition, December 2012.
Spiera PA and other. Aspartame: neuropsychologic and neurophysiologic evaluation of acute and chronic effects. Journal of Clinical Nutrition, September 1998.
Stegink, LD. The aspartame story: a model for the clinical testing of a food additive. July 1987.
Stegink, LD and others. Effect of sucrose on the metabolic disposition of aspartame. Journal of Clinical Nutrition, August 1990.
Stegink, LD and others. Erythrocyte L-aspartyl-L-phenylalanine hydrolase activity and plasma phenylalanine and aspartate concentrations in children consuming diets high in aspartame. Journal of Clinical Nutrition, December 1995.
Turnoff MJ and AM Alleva. Effect of drinking soda sweetened with aspartame or high-fructose corn syrup on food intake and body weight, Journal of Clinical Nutrition, June 1990
US Food and Drug Administration. Additional Information about High-Intensity Sweeteners Permitted for use in Food in the United States
_____ High Intensity Sweeteners